| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | -1203.9% | |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | |
| PEG | n/a | |
| Pr/Revenue | 18.1 | |
| Pr/Book | 1.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | -17.7% | |
| PBT | n/a | |
| EPS | n/a | |
| DPS | n/a |
| Year Ending | Revenue (€ m) | Pre-tax (€ m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-06 | 30.55 | (7.61) | (31.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-07 | 22.06 | (31.34) | (95.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-08 | 33.51 | (33.15) | (91.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 2.79 | (27.01) | (79.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 2.29 | (27.18) | (74.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| Year Ending | Revenue (€ m) | Pre-tax (€ m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-11 | 32.48 | (15.48) | (38.13)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-12 | 6.31 | (9.69) | (23.64)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 8.36 | (7.27) | (17.90)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| MDax & TecDax-Schlussbericht: Sparkurs treibt Me... | 20-Jun-2003 | FT Deutschland |
| MediGene: US-Patent für Tumortherapeutikum erteilt | 02-Feb-2001 | Handelsblatt |
| Currency | Euro |
| Share Price | € 1.15 |
| Change Today | € 0.03 |
| % Change | 2.68 % |
| 52 Week High | € 1.88 |
| 52 Week Low | € 0.86 |
| Volume | 23,297 |
| Shares Issued | 37.08m |
| Market Cap | € 42.65m |
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

You are here: research